特朗普政府发布GLOBE规则,Medicare药价试点仅覆盖四家企业
STAT+: Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal
特朗普政府发布针对医生诊所内用药的Medicare最终定价规则GLOBE,该试点仅适用于四家企业。作为“最惠国待遇”降价计划的一部分,与药物公司达成自愿协议的Medicaid供应商可豁免于GLOBE试点,而另一试点GUARD仍处于提案阶段。
![]()
Sept. 30, 2026
John Wilkerson, a Washington correspondent, is the author of D.C. Diagnosis, a twice-weekly newsletter about the politics and policy of health and medicine.
WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to only four companies.
The Global Benchmark for Efficient Drug Pricing, or GLOBE, is one of two mandatory pilot programs that are part of President Trump’s plan to get drugmakers to lower prices in Medicare to levels charged in other rich countries, a policy generally referred to as most-favored nation pricing. The other pilot, called GUARD, is still in the proposed stage.
The pilots are tied to Trump’s separate voluntary deals with drugmakers to offer MFN prices to drugs for Medicaid recipients. The companies that struck those deals are exempt from the GLOBE pilot, according to the model’s final rule.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com